LORRAINE HAINES: Open Payments
NPI 1912352154 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 18 payments from 5 companies in 2025. Trend: 2023 $408 · 2024 $145 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $218 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
Products named: VRAYLAR, BREZTRI, TRELEGY ELLIPTA, GVOKE HYPOPEN, INJECTAFER.
Industry payments across NV — which companies pay providers there.
